Navigation
- In re Gesture 25-1075.pdf
- Centripetal 23-2027.pdf
In an obviousness analysis, the Board must consider all properly presented evidence of secondary considerations (including copying) and assign it whatever weight the evidence warrants; it is reversible error to omit discussion of such evidence on the ground that the Board is not positioned to evaluate the broader litigation record.
- Mitek Systems 23-1687.pdf
IGT v. Zynga: Decision not to apply interference estoppel as a bar to institution is nonappealable
The Federal Circuit held that the PTO's decision not to apply interference estoppel as a bar to institution is a nonappealable institution determination under 35 U.S.C. § 314(d), with no Cuozzo “shenanigans” exception on these facts. The court also rejected a procedural challenge that the Board relied on a new, unargued unpatentability theory, finding adequate notice and opportunity to respond under IPR due-process/APA principles.
The court held that:
- Appl 23-1475.pdf
- In re Gesture 25-1075.pdf
- Ingenico 23-1367.pdf
- Alivecor 23-1512.pdf
- Amp Plus 23-1997.pdf
- Apple 23-1501.pdf
- Centripetal 23-2027.pdf
- Dolby 23-2110.pdf
- Global Health 23-2009.pdf
- Honeywell 23-1354.pdf
- IBM 24-1170.pdf
- In re PT Medisafe Tech. 23-1573.pdf [NEEDS_REVIEW]
- Kroy IP 23-1359.pdf
- Lashify 23-1245.pdf
- Lynk Labs 23-2346.pdf
- Merck 25-1210.pdf
- Shockwave Medical 23-1864.pdf
AMP Plus v. DMF: Appellant raised new grounds and presented inadequate analysis.
The Federal Circuit affirmed PTAB's opinion on remand that ELCO failed to show unpatentability of claim 22 because:
Stated the Court:
Other Holdings:
- Ancora 23-1674.pdf
- Appl 23-1475.pdf
- Apple 23-1501.pdf
- Bayer Pharma 23-2434.pdf
- Causam 24-1958.pdf
- Global Health 23-2009.pdf
- HD Silicon 23-1397.pdf
- Honeywell 23-1354.pdf
- IBM 24-1170.pdf
- IGT 23-2262.pdf
- Kroy IP 23-1359.pdf
- Lynk Labs 23-2346.pdf
- Qualcomm 23-1208.pdf
- Restem 23-2054.pdf
- Shockwave Medical 23-1864.pdf
- Alivecor 23-1512.pdf
- Amp Plus 23-1997.pdf
- Appl 23-1475.pdf
- CQV 23-1027.pdf
- Causam 24-1958.pdf
- Centripetal 23-2027.pdf
- Honeywell 23-1354.pdf
- IBM 24-1170.pdf
- IGT 23-2262.pdf
- In re Bayou Grand Coffee 24-1118.pdf [NEEDS_REVIEW]
- In re Riggs 22-1945.pdf
- Merck 25-1210.pdf
- Odyssey Logistics 23-2077.pdf
- Qualcomm 23-1208.pdf
- Sage Products 23-1603.pdf
- Shockwave Medical 23-1864.pdf